CTOs on the Move

Ameronc Inc

www.ameronc.com

 
Ameronc Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ameronc.com
  • 1 Perimeter Park S
    Birmingham, AL USA 35243
  • Phone: 205.408.5788

Executives

Name Title Contact Details

Similar Companies

CORE Ingredients and Packaging

CORE Ingredients and Packaging is a Opa Locka, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cottingham and Butler

Cottingham & Butler is the 35th largest insurance broker in the U.S. with over 600 employees dedicated to providing our clients with advice and insurance products to manage the risks they face. Our business model allows for assisting companies in three primary areas: 1. Transportation risks for large and small fleet operations 2. Risk management for manufacturing, construction, distribution and service industry clients. This area grew by over 40% in the last year. 3. Employee Benefits providing fully insured and self-funding options to cleints. Our benefits programs are fully integrated with clients to include FMLA, Health Risk Assessments and Short Term Disability services plus Executive Life and Disability services.

Minneola District Hospital

Minneola District Hospital is a Minneola, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

King's Medical Company

King's Medical Company is a Hudson, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.